|
OKUR Onkure Therapeutics Inc 1637715 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-15,346,000.00 |
| Balance Sheet |
|
Current Assets
|
$177,677,000.00 |
|
Assets
|
$179,353,000.00 |
|
Current Liabilities
|
$6,643,000.00 |
|
Liabilities
|
$7,245,000.00 |
|
Equity
|
$172,108,000.00 |
|
Shares Out
|
3343525.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-23,292,000.00 |
|
Investing Cash Flow
|
$-9,875,000.00 |
| Market Analysis |
Market Cap
|
$13,140,053.25 |
|
Price
|
$3.93 |
|
BVPS
|
51.48 |
|
PB
|
0.08 |
|
EPS
|
-0.31 |
|
FCF
|
$-23,300,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:48 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:38 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view OKUR documents filed with the SEC.
OKUR Filings
Clear
